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PENGEKSPRESAN RESEPTOR TERAKTIF PEMPROLIFERASI PEROKSISOM y 
(PPARy1- DAN PP.ARy2) DALAM LIMFOSIT T CD4+ NAIF DAN MEMORI 
ABSTRAK 
Set T CD4+ periferi boleh dibahagikan kepada dua kumpulan berfungsi 
berdasarkan ekspresi isofom di permukaan motekut yang mengandungi dua domain fosfat 
intrasellular dikenali sebagai CD45. Sel T memori mengekspres isoform yang mempunyai 
berat molekul terendah iaitu CD45RO manakala set T na·Jl mengekspres isofom CD45RA 
(manusia) atau CD45RB (tikus). CD45 iatah protein tirosina fosfatase yang memainkan 
peranan penting sebagai pengantara isyarat TCR dengan mengaktifkan lck melalui 
defosforilasi pengawalatur Tyros. Sel T CD4+ naif dan memori manusia berbeza dari segi 
keperluan untuk pengaktifan dan magnitud tindakbalas sel. Sejenis reseptor nukleus, 
reseptor teraktif pemptoriferasi peroksisom y (PPARy), dilaporkan terlibat di dalam 
pengawalaturan aktiviti sel imun seperti makrofaj atau monosit dan limfosit T. 
Memandangkan peranannya di dalam pengawalaturan imun~ kajian terkini dijalankan 
untuk menentukan tahap pengekspresan PPARy di dalam set T CD4+ naif dan memori 
kerana tahap ekspresi PPARy berkemungkinan berbeza di dalam isofom CD45 yang 
berlainan. Tambahan lagi, perbezaan oorak pengisyaratan dan rembesan sitokin bagi se1 
T subset tersebut mungkin disebabkan oleh gabungan dengan isofom PPARy-
kemungkinan yang masih be1um dieksplorasi setakat ini. Bagi mengenalpasti peranan 
PPARr di dalam pengawalaturan pengaktifan sel T CD4+ nalf dan memori, ciglitazone 
yang merupakan agonis bagi PPARy digunakan untuk memodulasi status pengaktifan se1 
T CD4+ nail dan memori selain pengekspresan PPARy ~ndiri dan sitokin terpilih. Denga~ 
menggunakan Real-Time PCR, sel T CD4+ nm1 dan m~. talc teraktif tidak 
mengekspres PPARy1 dan PPARy2 manakala sel T CD4+ naif dan memori teraktif 
mengekspres reseptor tersebut pada paras yang tinggi dengan pengekspresan PPARy2 
lebih tinggi berbanding PPARr1 di dalam kedua-dua jenis sel (p<0.01). Tambahan lagi, 
ekspresi PPARy1 lebih tinggi di dalam se1 memori ter.aktif berbanding sel T CD4+ naif 
teraktif {p<O .05} manakala tiada perbezaan bagi pengekspresan .PPARr2 di dalam kedua-
dua sel yang teraktif. Penambahan agonis bagi PPARy iaitu cigtitazone meningkatkan 
pengekspresan PPARy1 kira-kira 61 kali dan 175 kaJi masing-masing di dalam seJ T CD4+ 
naif dan memori yang teraktif (p<0 .. 01). 8erbeza dengan PPARy1, penambahan 
ciglitazone mengurangkan ekspresi PPARy2 kira-kira 650 kali dan 140 kali di dalam sel T 
CD4+ naif dan memori teraktif {p<0.01 ) .. Tambahan lagi, tahap ekspresi gen TGF-Ji dan IL-
1 f3 adalah tinggi di dalam sel T C04+ naif dan memori yang tak teraktif tetapi berkurangan 
di dalam keadaan teraktif (p<0.01). Gen IL-8 mengekspres pacta tahap yang rendah di 
dalam set T CD4+ naif dan memori yang tak teraktif tetapi meningkat di dalam keadaan sel 
tersebut yang teraktif (p<0.01). Wafaubagaimanapun tiada perbezaan bagi ekspresi sitokin 
tersebut di antara sel T CD4+ naif dan memori di dalam kedua-dua keadaan. IL-2, IFN-y, 
IL-5, ll-13, TNF-a., GM-CSF dan IL-6 hanya mengekspres di dalarn set T CD4+ naif dan 
memori yang teraktif tetapi tidak dalam keadaan yang tak tetaktif. Tahap pengekspresan 
IL-2 dan IL-13 adalah tinggi di dalam sef naif yang teraktif berbanding se1 T CD4+ memori 
teraktif (p<0.01 ). Berbeza dengan IL-2 dan IL-13. tahap pengekspJesan IFN-ty adatah 
tinggi di dalam sel memori teraktif berbanding sel nail yang teraktif (p<0.05). 
Walaubagaimanapun, tiada perbezaan di dalam pengekspresan ll-5, IL-6, TNF-a dan 
GM-CSF di antara kedua-dua jenis sel yang teraktif. Penambahan ciglitazone 
mengurangkan tahap pengekspresan TGF-fl, IL-1[i,IL-8, IL-2. IFN-y, IL-5, TNF-a. dan GM-
CSF di dalam sel T CD4+ nail dan memori yang teraktif. Peningkatan PPARy1 dan 
perencatan ekspresi PPARy2 di dalam sel T CD4+ nail dan memori di dalam kehadiran 
xvi 
ciglitazone mencadangkan bahawa isoform PPARy mungkin mempunyai fungsi yang 
berbeza dalam pengawalaturan sel T. Pengekspresan gen sitokin yang terpilih di dalam 
sel T CD4+ naif dan memori yang teraktif adaJah konsisten dengan kajian terdahulu. 
Mekanisma sebenar bagaimana PPARr merencat pengekspresan sitokin di dafam sel T 
CD4+ na"1T dan memori teraktif atau isoform PPARy yang mana bertanggung jawab 
terhadap kesan ini masih belum dapat di pastikan. PPARy berkemungkinan merencat 
pengekspresan gen sitokin di dalam sel subset yang teraktif melalui interaksi dengan NF-
KB. AP-1 dan STATs yang merupakan faktor transkripsi yang penting bagi sitokin tersebut 
sebagaimana kajian terdahulu di dalam set yang lain .. 
xvil 
THE EXPRESSION OF PEROXISOME PROLIFERA TOR-ACTIVATED RECEPTOR y 
(PPARy1 AND PPARy2) IN NAi.VE AND MEMORY CD4+ T LYMPHOCYTES 
ABSTRACT 
Peripheral CD4+ T cells can be divided into two functional groups based on the 
expression of distinct isoforms of the surface molecule that contains an intracellular two-
domain phosphatase portion, known as CD45. Memory T cells express the lowest 
molecular weight CD45RO isofonn. whereas naive T cells express CD45RA (human) or 
CD45RB (mouse) isoforms. CD45 is a protein tyrosine phosphatase which plays an 
important role in TCR-mediated signaling through its activation of Lck by de-
phosphorylating the regulatory Tyros. Human naive and memory CD4+ T cells differ in the. 
requirements for activation and magnitude of the cellular responses. The nuclear receptor, 
peroxisome proliferator-activated receptor 1 {PPARy) has been reported to be involved in 
regufatinQ the activities of immune cells such as macrophages or monocytes and T 
lymphocytes. Given their roles in immune regulation, the current study was carried out to 
determine the expression of PPARy in human naive and memory CD4+ T cells since it is 
possible that PPARy may be differentially expressed in the different isoforms of CD45. In 
addition. the differential signaling patterns and cytokine secretion of these subsets of T 
cells may require engagement with PPARy isoforms ... a possibility that has not been 
explored thus far. To further dissect the rote of PPARy in the regulation of naive. and 
memory CD4+ T cell activation, the PP AR.y agonist, ciglitazone, was used to modulate the 
activation status of naive and memory CD4+ T cells as wetl as the expression of PPARy 
itself and selected cytokines. Using Real .. Time PCR. unstimulated naive and memory 
CD4+ T cells were found not to express PPARy1 and PPARy2, whereas stimulated naive 
xviii 
and memory CD4+ T cells express high levels of these receptors with PPARy2 expression 
being higher than PPARy1 in both cell types (p<0.01). In addition, the PPARy1 expression 
was higher in stimulated memory as compared to stimulated naive C04+ T cells {p<0.05) 
whereas there was no significant difference between PPARy2 expression in both types of 
stimulated cells. The addition- of the PPARy agonist, ciglitazone signifiCantly increased the 
expression of PPARy1 by about 61-fold and 175-fold in stimulated naive and memory 
CD4+ T cells respectively (p<0.01). In contrast to PPARy1, the addition of ciglitazone 
significantly decreased the expression of PPARy2 by about 650-fokl and 140-fold in 
stimulated na"ive and memory CD4+ T cells respectively {p<0.01). In addition, the 
expression levels of TGF-)3 and· IL-1 J3 gene were higher in unstimulated naive and memory 
CD4+ T cells but decreased in their stimulated state (p<0.01). lL-8 gene was expressed at 
low levels in unstimulated but elevated in stimulated naive and memory CD4+ T cells 
(p<0.01}. However, there were no significant differences in the levels of these cytokines 
between naive and memory CD4+ T celts between both states. IL-4 lFNy, IL-5, IL-13, 
TNFa, GM-CSF and IL-6 were only expressed in stimulated naive and memory CD4+ T 
ceUs but not. in their unstimulated state. The expression levels of IL-2 and IL-13 were 
significantly higher in stimulated naive as compared to stimulated memory C04+ T cells 
(p<0 .. 01 ). In contrast, the expression levels of IFNy were significantly higher in stimulated 
memory as compared to stimulated naive CD4+ T cells (p<0.05). However, there were no 
significant differences in the expression of IL-5, IL-6, TNFa and GM..CSF between both 
stimulated cell types. The addition of ciglitazone. decreased the expression levels of TGF-
p, IL-1p, IL-8, IL-2, IFNy, IL-5, TNFa. and GM-CSF in stimulated memory and na"ive CD4+ 
T cell& The induction of PPARr1, and suppression of PPARy2 expression in naTve and 
memory CD4+ T cells in the p~sence of ciglitazone suggest that the PPARy isoforms may 
have different functions in T cell regulation. The expreqi~n of $elected cytokine genes in 
I :' •' 
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activated naive and memory CD4+ T cells is consistent with previous studies. The exact 
mechanism of how PPARy inhibit cytokine expression in stimulated naive and memory 
CD4+ T cells or which PPARy isoforms is responsible for this effect remain uncertain. It is 
possible that PPARy inhibit the expression of cytokine genes in these stimulated cell 
subsets. via interacting with NF-KB, AP-1 and STATs. which is important transcription 
factors for these cytokines as shown by previous studies in other cells. 
XX 
1.1 T cell development 
1.1.1 Generation ofT cells 
CHAPTER ONE 
INTRODUCTION 
T cell development occurs in the thymus (Surh and Sprent, 2005). The thymus is a multi-
lobed organ consisting of cortical and medullary areas surrounded by a capsule (Figure 
1.1). T cell precursors enter the subcapsular cortical areas, where they encounter 
networks of cortical epithelial cells (the thymic stroma) and undergo a period of 
proliferation. After differentiation. they migrate from the cortex towards the meduUa of the 
thymus. 
In the thymic cortex, progenitor cells derived from the bone marrow differentiate into T cell 
lineage by rearranging the TCRJ3 chain and expression of the pre-TCR complex which lead 
to multiple changes including, massive expansion of 'double negative• (ON) cD4- a-
precursors by IL-7, upregulation of CD4 and CDS on the 'double-positive' (DP) c04• a• 
thymocytes, and rearrangement of TCRa chain for expression of the TCR (Michie et al., 
2002; von Boehmer, 2004) (Figure 1.1). 
DP thymocytes undergo positive selection to remove cells that have significant TCR 
reactivity for self~HC/peptide complexes. After positive selection, DP cells migrate from 
the cortex to the medulla and differentiate into single-positive CD4 + a- and CD4- a+ cells. 
During this differentiation process, negative selection takes over to destroy autoreactive T 
cells with high avidity for self components (Sprent et at .. , 1995; Starr ~tat., 2003) .. After 
positive and negative selection, depending on the affinity and the conwxt of such binding, 
1 
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Figure 1.1 Pathways ofT cell development (modified from Mehr eta/., 1995) 
2 
95% of developing DP cells die via apoptosis while only a small fraction ( <5%) of DP ceUs, 
move in1o the periphery to form the T cell pool (Surh and Sprent. 2005). 
In addition to T ceUs expressing o:J3 TCR, which constitute the majority of T cells in adultst 
there is a lineage ofT cells expressing the yo TCR. These cells are abundant in various 
epithelial tissues, such as the epidermis {in mice but not humans), intestinal epithelium, 
uterus and tongue .. The y5 T ceUs recognize both exogenous antigens such as viral and 
protozoal peptides. and autoantigen such as heat shock proteins_ Moreover, the peptides 
can be presented by either class I or class II MHC molecules, and there are several 
studies which suggest the y8 T cells do not require antigen to be presented by MHC 
molecules at all (Adams et al., 2005). 
1.2 T cell recognition 
Approximately 90-95% of peripheral blood T cells are a.J3 T cells. aJJ T cells are mainly 
divided into CD4+ helper T cells and COS+ cytotoxic T cells. CD4+ T cells recognize their 
specific antigens in association with the major histocompatibility complex (MHC) dass II 
molecules, whereas COS+ T cells recognizes antigen in association with MHC class I 
molecules. 
1.2.1 Antigen presenting cells 
Antigens must be processed by antigen presenting cells (APCs) before presentation toT 
lymphocytes. The APCs which are essential forT cell activation includes dendritic cells 
(DCs}, mature B cells and macrophages (Sille eta/., 2005). Des are found in lymphoid 
tissues, connective tissues and epithelial cells (Bell et al., 1999). OCs capture antigens in 
peripheral tissues and then move to lymph nodes, where they express high levels of 
3 
adhesion and ·co-stimulatory molecules, as well as MHC class II antigens (Bell et a7., 
1999)~ DCs stop synthesis of these molecules when they migrate but express high levels 
of MHC class II molecules containing peptides from antigens produced by tissues where 
the DCs originated (Bell eta/., 1.999). 
8 ceUs can bind to a specific antigen, internalize it and then degrade it into peptides whiCh 
associate with MHC class II . molecules~ B cells which have high affinity antigen receptors 
{lgM or lg.O) are the most potent APC at low concentrations of antigens because other 
APCs cannot capture enough antigens (MeUman et al., 1998). B celis do nOt eXpress eo-
stimulatory molecules such as 87 but · can be induced · to produce 87 by bacteria1 
constituents. 
Macrophages ingest microbes and particulate antigens by ·phagocytosis for -processing 
and presentation by MHC class II molecules (Kalish, 1995). High levels of MHC and co-
stimulatory molecules such as 87 are induced by the uptake of bacteria which is enhanced 
by receptors specific to certain surface components of bacteria (Mellman et at., 1998). 
These APCs are illustrated in Figure 1.2.. 
1.2.2 Antigen presentation by major histocompatability complex molecules 
The MHC is involved in presentation of antigens to T cells. The human MHC class I 
molecules includes the HLA-A, B and C whereas the human MHC class II molecules 
comprise of the DR, OP and DQ (van den Elsen et at., 2004). The genetic locus of MHC 
class 1 and II is presented in Figure 1.3. MHC class I and II molecules are members of the 
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Figure 1.2 Antigen presenting cells (APCs) 
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Figure 1.3 The genetic organization of MHC class I and II molecules 
6 
have similar structure and amino acid homology to the constant and variable domains of 
immunoglobulins (Kalish, 1995}. 
i) MHC class I molecules 
MHC class l molecule consists of a heavy chain with three immunoglobuUn domains, in 
noncovalent association with Pz-microglobutin (van den E1sen et a/., 2004) and are 
expressed on all nucleated ceus (Kalish, 1995) (Figure 1.4) .. The first two domains of the 
alpha chain, a1 and a2 form a "groovelf that binds a peptide and together with J3:r 
microglobufin, the three member complex allows for its stable expression on the cell 
surface {Anderson eta/., 1993). MHC class I molecules bind peptides consisting of 8 to 10 
amino acids (Falk et a/., 1993). The peptide-binding groove contains pockets with amino 
acid residues which formed specific interactions with the amino and carboxylic acid 
terminals of the peptide (Wilson and Fremont, 1993) .. 
il) MHC class II molecules 
MHC class II molecules are comPQSed of two a. chains and two f} chains (Kalish, 1995) 
(Figure 1.4). The peptide-binding groove of MHC class II molecules is open at the ends 
and enables binding of longer peptides compared to the MHC class I molecules 
{Rudensky et a/., 1991 ). In the absence of stimulation, MHC dass II molecules are only 
expressed on professional APCs such as macrophages, mature B ceiJs, Langerhans cells 
and dendritic cells (Kalish, 1995). The expression of MHC class II molecules can be 
induced by interferon gamma on kerattnocytes and endothelial cells (Kalish, 1995). 
1.2.3 Antigen processing 
Antigen processing involves antigen degradation into peptide fragments which are 
recognized by T cells via the TCR. A minority of peptide· fragments from protein antigens is 
7 
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Figure 1.4 MHC molecules (adapted from Roitt eta/., 2001) 
8 
able to bind to particular MHC molecules. Furthermore, different MHC molecules engage 
with different sets of peptides. 
i) Endogenous antigens 
Protein antigens arising from inside the cell (endogenous antigens) are processed by the 
endogenous pathway for presentation to T cells. Examples of endogenous antigens are 
viral antigens, transplantation antigens and tumor-associated antigens (Kalish, 1995). 
Endogenous antigens derived from cytoplasmic proteins (Moore et a/., 1988) are targeted 
by conjugation with ubiquitin (Michalek et a/., 1993; Ciechanover and Schwartz. 1994) 
facilitating them to be degraded into peptides by the proteosome complex (Yang et aL, 
1992). Peptides derived from the degradation of cytoplasmic proteins are transported from 
the cytoplasm to endoplasmic reticulum (ER) by the transporter-associated antigen 
processing (TAP1 and TAP2) molecules {Spies eta/., 1990; Attaya et al., 1992; Colonna et 
al., 1992; Spies eta/., 1992; Suh eta/., 1994). 
Within the ER, a series of chaperone proteins, induding calnexin, calreticulin, ERp57, and 
immunoglobulin binding protein (Bip) facilitates the proper folding of MHC class 1 and its 
association with J32 microglobulin. The partially folded MHC class I molecules then interact 
with TAP via tapasin. Newly synthesized MHC class I molecules cornplexed with peptides 
are then transported from the ER through the Golgi complex to the cell surface for 
recognition by CDS+ T cells (Cox eta/., 1990) (Figure 1.5). 
li) Exogenous antigen 
Protein antigens from outside the ceH (exogenous antigens) are processed by the 
exogenous pathway for presentation to T cells. Examples of exo~nous antigens are 
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Figure 1.5 Antigens processing pathways (cited from http://www.anzies.com.au) 
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dust mites (Kalish, 1995). Exogenous antigens are internalized in endosomes by 
phagocytosis or pinocytosis. The endosomal vacuoles fused with lysosome to form 
lysosome/endosome compartment. This compartment has an acidic pH and contains 
multiple degradative enzymes such as acid proteases and cathepsins (Rodriguez and 
Diment, 1992) to degrade the exogenous antigen into peptides. MHC class II molecules 
are transported into this lysosome/endosome compartment to bind to the processed 
peptides (Neefhes and Ploegh, 1992). 
MHC class II molecules are firstly synthesized in the ER (Kafish, 1995). The invariant 
chain facilitates MHC class II export from ERin a vesicle (Teyton eta/., 1990). This vesicle 
will fuse with endosome containing degraded proteins and then broken down to leave only 
a small fragment called CLIP which responsible to inhibit the binding of peptides to the 
MHC class II molecules before arrival in the endosome/lysosomal compartment {Bodmer 
et a/., 1994). Peptides generated in the lysosome/endosome compartment are presented 
by MHC class II molecules on the cell surface for recognition by C04+ T cells (Fabbri et 
a/., 2003; van den Elsen et at., 2004) (Figure 1.5). 
1.2A Antigen presentation to T lymphocytes 
Antigen presentation is the process by which T cells recognize antigen on the surface of 
an APC (Kalish, 1995). The peptide-MHC (pMHC) complex is recognized by af3 T cells 
through their TCR (Garcia and Adams, 2005). The TCR is a genetically recombined 
receptor and analogous to an immunoglobulin molecule (Garcia and Adams, 2005). It is a 
heterodimer consisting of a and p chain held together by disulfide bonds, .each with one 
variable and one constant domain. However, 5% Of the T cells, especially those found in 
the skin and mucous layers, have TCR consisting of the 1 and o chain. Va. and vp are the 
hypervariabte regions of TCR, that form three complementary detetmining regions (CDRs} 
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on each chain. CDR1 and CDR2 usually bind to MHC while CDR3 usually binds to the 
peptide (Garcia and Adams, 2005). TCR has a very short cytoplasmic tails, Which is not 
appropriate in signal transduction. So it is expressed on the membrane together with the 
signal transduction complex, CD3. as TCR complex (Figure 1.6). CD3 is composed of four 
invariant polypeptides called y, e. o and t;. The CD3 chains are organized as heterodimers 
of either rs or 8e and a homodimer of ~~- The y, o and s chains have negatively charged 
transmembrane region which forms salt bridges with positively charged transmembrane 
regions of TCR. The l; chain comprises a small extracellular domain of only nine amino 
acids which includes the disulphide bond, a transmembrane segment including a 
negatively charged residue and a large cytoplasmic tail. All CD3 chains contain one 
immunoreceptor tyrosine activation motif (IT AM), while three copies of ITAMs are present 
on each of the l; chain•s cytoplasmic tail (Chan eta/., 1994). FoDowing antigen binding, the 
ITAMs will associate with tyrosine kinase to initiate intracellular signaling cascade. CD4 
and COS are co-receptor molecules that bind to the non-polymorphic regions of MHC 
molecules and enhance the binding avidity of T cells to the APC. CD4 is a monomeric 
protein with four domains where two distal domains that bind to the f32 domain of MHC 
class II. COB is an a and p chain heterodimer, each with one domain and a long extended 
region. COB binds to the a3 domain of MHC dass I. Both CD4 and C08 have Lck 
associate with its cytoplasmic tail to initiate signal transduction (Figure 1.6). The Lck or 
p561ck is a lymphocyte-specific tyrosine kinase of 56 kDa that is attached to the intracellular 





Figure 1.6 TCR complex (cited from http://www.immuno.path.cam.ac.uk) 
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1.2.5 Second signal-co-stimulator molecules 
Co-stimulatory molecules do not bind to antigen directly but act when TCR binds to 
antigen. The main functions of co-stimulatory and other accessory molecules are to 
transduce signal for the complete activation of T cell, ads as adhesion molecules to 
stabilize the interaction between T cells and APCs and facilitate the migration of T cells. T 
cells that do not receive co-stimulation become anergic (not functioning) and this is 
important to ensure that self-antigen will not activate self-specific T cells that escaped 
negative selection (Tan eta/., 1993). There are perhaps many co-stimulator molecules that 
are involved in the T cell activation process. Some of the important ones are briefly 
described below. 
i) B7-CD28 
87 molecules are expressed mainly by professional APCs such as dendritic cells, 
macrophages and mature B lymphocytes. 87-1 and 87-2 are structurally similar, single 
chain glycoprotein, each with extracellular lg-like domain, a transmembrane segment and 
cytoplasmic tail. Co-stimulation ofT cells mainly comes from the binding of 87-1 (COSO) 
and 87-2 (CD86) on APC to the CD28 molecule on T cell membrane {Turka et at., 1990) 
(Figure 1 .. 7). The binding between these molecules brings upon the expression of anti .. 
apoptosis proteins such as Bcl-x, production of cytokines such as IL-2 and proliferation 
and differentiation ofT cells. 
II) Cytotoxic T lymphocyte associated antigen 4 (CTLA-4) (CD152) 
Activated T cells express CTLA-4 instead of CD28 .. CTLA-4 is also a receptor for 87 
molecules. Its binding to 87 inhibits T cell function by interrupting signals transduced by 
CD28. Mutant T cell that lack CTLA-4 cannot be deactivated, resulting in the increase 














Figure 1.7 Critical molecules involved in antigen presentation (adapted from Roitt eta/. 
2001) 
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iii) Other accessory molecules 
CD2 act as an adhesion molecule by binding to LFA-3 (CD58) molecules found on a wide 
range of cells (Damle et at., 1992; Perlmutter, 1993) {Figure 1.7). lt is involved in the 
interaction between T cells and APCs. CD11 b/CD18 is also an adhesion molecule Hke 
CD2. It binds to the intracellular adhesion molecule-1 (ICAM-1) on APCs or target cells 
(Damle et a/., 1992~ Perlmutter, 1993) (Figure· 1 .. 7). Activated CD4 cells express. 
CD401igands (CD40L) that binds to the CD40 molecules on. B cells and macrophages .. The-
binding induces the activation of B cell and macrophages accompanied by the induction of 
87 molecule expression on APC and enhancement of proliferation and differentiation of T 
cells. 
1.2.6 T cell activation 
T cell activation is initiated by the interaction of the TCR with peptide-MHC complexes. 
TCR engagement triggers the tyrosine phosphorylation of the IT AM present on the TCR-
associated CD3-l; subunit by the protein tyrosine kinase (PTK) Lck (Chan et al., 1994; 
Myung et a/., 2000). All ITAMs contain two sequence elements (Tyr-X-X-Leu) with 
potential tyrosine phosphorylation sites which is separated by seven or eight variable 
amino acids (Hegedus et at., 1999) (Figure 1.8). When two tyrosines in a single motif are 
phosphorylated, IT AM forms a binding site for a cytoplasmic PTK, known as ZAP-70. This 
recruitment initiates ZAP-70 activation and downstream signaling cascade such as the 
activation of phospholipase ~1 and protein kinase C (PKC). 
Engagement of TCR induces activation of phospholipase Cy1 (PLCy1), which catalyzes 
the hydrolysis of inositol phospholipids (PIP2) to produce inositol 1, 4, 5-triphosphate (IP3) 
and diacylglycerol (DAG) which activate two distinct signaling pathways in T cells (van 
Leeuwen and Samelson, 1999}. IP3 migrate from the cytosol to the endoplasmic reticulum, 
16 
r-X-X-Leu-X-X-X-X-X-X-X-Leu-X-X-Tyr 
Figure 1.8 The IT AM complex 
The ITAMs contain two sequence elements (Tyr-X-X-Leu) separated by 7 or 8 variable 
amino acids. When the tyrosine residues are phosphorylated, IT AM acts as a docking site 
for the tyrosine kinase, ZAP-70. 
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where it binds' to its receptor and initiates the release of internal Ca2+ stores which then 
cause a rapid increase in the cytosolic free Ca2+ ion concentration (Lewis, 2001). Cytosolic 
free Ca2+ acts as a signaling molecule by binding to calmodulin (Ca2 .... dependent regulatory 
protein) (Quintana et al., 2005). This calcium-calmodulin complex activate several 
enzymes especially calcineurint a Ca2+ -calmodulin dependent protein phosphatase which 
subsequently dephosphorylates the nuclear factor of activated T cells (NFAT) (Rao et al., 
1997). This transcription factor is an inducible regulatory complex critical for transcriptional 
induction of IL-2 in activated T cells, but also regulate the transcription of various genes 
such as cytokines, cell surface receptors and regulatory enzymes (Rao et al., 1997; 
Martinez-martinez et a/.t 2004). The increase in free cytosotic C<f+' results in the 
translocation of inactive cytosolic PKC to the cell membrane.. DAG activates PKC by 
inducing a conformational change that becomes the catalytic site of the kinase accessible 
to ~ubstrate (Lewis, 2001 ). Although DAG activates multiple isofonns of PKC, only PKCa is 
required forT cell activation in vivo (Sun et al., 2000; Pfeifhofer eta/., 2003). The GTP 
bound Ras (GTP·Ras) functions as adivator of a cascade of enzymes namely mitogen· 
activated protein (MAP) kinases. The MAP kinase cascade consist of three different 
kinases, the extracellular signal-regulated kinases (ERKs) (Schaeffer and Weber, 1999), 
p38 Map-kinases (Han and Ueitch, 1999) and c-Jun NH2-tenninal kinases (JNKs) (Davis, 
2000). The activated ERK phosphorylates Elk1, which then stimulates transcription of Fos, 
the first component of the activation protein-1 (AP-1) (Genot eta/., 1996). Parallel to this 
pathway, the adapter protein also activates a GTP exchange protein namely Vav that acts 
on Rae. This Rac-GTP initiates the activation of the c-Jun by JNK at Ser-63 and Ser-73 
within the transactivation domain (Whitmarsh and Davis; 1996). c-Jun heterodimerlzes 
with c-Fos to form AP-1, the regulatory element in the IL-2 promoter that is important for 
early transcription of the IL-2 gene (Durand et al., 1988). The brief overall intracellular 
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Figure 1.91ntracellular signaling in T cell activation (adapted from Roitt eta/., 2001) 
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1.3 The protein tyrosine phosphatase, CD45 
The protein tyrosine phosphatase (PTPase) CD45 is a transmembrane glycoprotein 
expressed on the surface of all nucleated haematopoietic cells except mature erythrocytes 
and platelets (Trowbridge and Thomas, 1994). CD45 consists of its splice variants namely 
CD45RA, CD45RB, CD45RC and CD45RO. CD45 comprises up to 10% of the T and 8 
cell surface molecules (Sasaki et al., 2001 ). This high level of expression coupled with the 
differential expression of selected variants on naive and memory T cells and their role in 
immune regulation makes the CD45 molecules are important molecule to be investigated. 
1.3.1 Structure of CD45 
CD45 is expressed in muHiple isoforms as a result of alternative RNA splicing of exon 4 to 
s (Trowbridge and Thomas, 1994; Alexander et at~, 1997) with a molecular weight range 
' 
from 180-240 kDa. The high molecular weight isoforms contain exon 4/A, 518 and 6/C 
(CD45ABC) and the low molecular weight is the CD45RO isoform (Figure 1.10). The 
genetic organization of CD45 is shown in Figure 1.11. The CD45 ectodomain is 
characterized by the three alternatively sp1iced exons A, 8 and C that are rich in serine, 
threonine and proline residues, a cysteine rich domain followed by fibronectin (FN) type Ill 
repeats at the N-tenninus (McNeill eta/., 2004). The ectodomain is heavily glycosylated, 
mainly N-linked in the FN-111 and cysteine rich regions and O..Jinked in the A, B and C exon 
encoded regions (McNeill et al .• 2004). The CD45RO lacks the A, 8 and C exon encoded 
region (McNeill et a/., 2004). The intracytoplasmic tail of CD45 is highly conserved 
between all mammalian species and contains the so-called 01-domain which has PTPase 
activity, whereas the 02-domain has no signifiCant PTPase activity due to changes in 
critical amino acids required for catalytic activity (Sasaki eta/., 2001). 
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Figure 1.10 The CD45 structure (adapted from McNeHI eta/., 2004) 
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Figure 1.11 Genomic organization of CD45ABC (adapted from Fukuhara et al.., 2002) 
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1.3.2 Biological functions 
CD45 is an important positive regulator of TCR and BCR mediated signaling required for 
the activation and development of lymphocytes (Kishihara et al., 1993; Byth et al., 1996). 
CD45 PTPase activity is required for histamine degranulation following lgE receptor cross-
linking in mast cells (Berger et al., 1994). CD45 expression is also invOlved in antigen 
receptor-driven thymocyte maturation and B cel1 selection (Kishihara eta/., 1993; Byth et 
at., 1996). Mutation in the protein tyrosine phosphatase receptor type C (PTPRC} gene 
encoding CD45 and abnormalities in the expression of CD45 splice variants increased the 
incidence of severe combined immunodeficiency disease (SCID) in humans (Kung et al., 
2000). 
1.3.3 CD45 regulates protein tyrosine kinase, Lck 
An important early step in TCR signaling is the phosphorylation of ITAMs by the Src-like 
protein tyrosine kinase Lck (lrles et a/., 2002) .. This kinase is located in glyosphingoUpid-
enriched membrane {GEMs) and its activity is regulated by the opposing actions of the 
CD45 PTPase and the carboxyl-terminal Src kinase (Csk) (Bergman et al., 1992; Thomas 
and Brown, 1999). Phosphorylation of Ty,SOS in Lck by Csk leads to an Src homology 
domain 2 (SH2)-mediated intramolecular interaction which inhibits activation of Lck by 
trans-autophosphorylation of Ty~ in its catalytic domain (Sicheri and Kuriyan, 1997). 
CD45 dephosphocytates the Ty,SOS to relieve this inhibition (Yamaguchi and Hendrickson. 
1996; Sicheri and Kuriyanr 1997) allowing the Lck to promote full phophorylation of the 
IT AM motifs of the CD3/' components and faalitate the recruitment and activation of the 
ZAP-70 tyrosine kinase (Leitenberg et at .• 1999). In addition, C045 may maintain Lck in an 
"open" configuration which enhances Lck. interaction and recruitment of various adapter 
proteins and other signaling molecules into large macromolecular complex that facilitates T 
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cell activation and IL-2 secretion independently of Lck kinase activity (Collin and Burakoff, 
1993; Sieh eta/., 1993; Xu and Littman, 1993). 
1.3.4 CD45 inactivate Jak family kinase 
The Janus .. kinase/signal transducers and activators of transcription (Jak/STA T) pathway 
are involved in the signaling of many cytokines (Scott eta/., 2002). Following stimulation of 
cytokine receptors, Jaks (Jak1, Jak2, Jak3 and Tyk2) are phosphorylated on their tyrosine 
residues and are activated to phosphorylate STATs. STATs phosphorylation by Jaks 
results in dissociation and homo- or hetero.dimerization and ultimately translocation to the 
nucleus where they can rapidly and specifically activate target genes (lvaskhiv, 1995). 
CD45 dephosphorylates all Jaks and inhibit the secretion of cytokines (Sasaki et al., 
2001). CD45 also negatively regulates JL .. 13 mediated cellular proliferation. erythropoetin-
dependent hematopoiesis and antiviral responses in vitro and in vivo (Sasaki et at., 2001 ). 
1.4 Naive CD4+ T cells 
Naive CD4+ T cells are thymic emigrants which had already undergone various maturation 
and selection processes in the thymus and populate the peripheral blood and secondary 
lymphoid organs such as spleen, lymph nodes and the mucosal-associated lymphoid 
tissue. They have not been activated by specific antigen in vivo {Van Uer and Baars, 
1999). These cells can be characterized by the expression of the high molecular weight 
isoform of CD45, CD45RA, and low levels of 131 and P2 integrins (Sanders et a/., 1988; 
Prince et al., 1992; Masopust et al., 2004). Naive CD4+ T cells express CCR7 and the 
peripheral lymph node homing receptor CD62L that facilitate the migration of these cells to 
the T cell areas of the secondary lymphoid organs (SaOusto et a/., 1999; Masopust et a/., 
2004; Sallusto et al., 2004). Naive CD4+ T cells require the engagement not only of TCR, 
but also the costimulatory receptor, CD28 for complete activation which leads to 
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